Table 3.
Results of demographic and outcome comparisons
| MVP 2012* vs. cumulative control | MVP 2012* vs. MVP 2011 | |
|---|---|---|
| P value | P value | |
| Demographics | ||
| Sex† | 0.552 | 0.509 |
| Age | 0.375 | 0.779 |
| Retreatment‡ | 0.046§ | 0.051 |
| Type of tuberculosis | ||
| Pulmonary, sputum positive | 0.205 | 0.880 |
| Pulmonary, sputum negative | 0.503 | 0.204 |
| Extra-pulmonary | 0.981 | 0.163 |
| Unknown | 0.015§ | 0.163 |
| HIV status | ||
| HIV-positive | 0.442 | 0.241 |
| HIV-negative | 0.636 | 0.238 |
| Unknown | 0.443 | 0.953 |
| Patient knows HIV status and received counseling | ||
| Yes | 0.981 | 0.435 |
| No | − | − |
| Unknown | 0.981 | 0.953 |
| Enrolled on CPT, where applicable (of all patients/of those applicable) | ||
| Yes | 0.636/0.347 | 0.497/0.204 |
| No | − | − |
| Unknown | 0.308/0.347 | 0.140/0.204 |
| Enrolled on ART, where applicable (of all patients/of those applicable) | ||
| Yes | 0.472/0.696 | 0.932/0.630 |
| No | 0.420/0.326 | 0.967/0.832 |
| Unknown | 0.607/0.990 | 0.217/0.570 |
| Outcomes | ||
| Cured | 0.003¶ | 0.050§ |
| Success | 0.464 | 0.484 |
| Lost to follow-up | 0.090 | 0.068 |
| Dead | 0.071 | 0.017§ |
| Lost or dead | 0.010¶ | 0.002¶ |
| Negative outcomes | 0.008¶ | 0.002¶ |
*
Enrolled on eCompliance.
†
Given records with unknown gender the values report reflect the most statistically significant Z and P values.
‡
Retreatment, a patient who is returning after default, or receiving retreatment after initial treatment failure, or who has relapsed.
§
Statistically significant at P < 0.05.
¶
Statistically significant at P < 0.01.
A comparison of proportions for the demographic characteristics and outcome indicators for the MVP 2012 cohort, who received the treatment, against the proportions for the control group in the MVP cluster in 2011 and for all of the patients in a control group, respectively.